Research ArticleTuberculosis

Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis

See allHide authors and affiliations

Science Translational Medicine  13 Nov 2019:
Vol. 11, Issue 518, eaaw6635
DOI: 10.1126/scitranslmed.aaw6635

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

No eLetters have been published for this article.

Stay Connected to Science Translational Medicine

Navigate This Article